Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
Calle-Pascual
A
A
Garcia-Honduvilla
J
J
Martin-Alvarez
P J
PJ
Calle
J R
JR
Maranes
J P
JP
D020909:Acarbose; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D009765:Obesity; D010919:Placebos; D012307:Risk Factors; D014312:Trisaccharides / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D010919:Placebos; D014312:Trisaccharides; D020909:Acarbose